Shanxi Tongda Pharmaceutical CO., Ltd.
As of 18 November 2026, for the company name Shanxi Tongda Pharmaceutical CO., Ltd. as recorded, the chemical-drug catalogue lists 28 active records with this name as holder; 22 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
64 acceptance records as first applicant, grouped into 50 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Allopurinol Tablets 2 records · Latest accepted 2026/10/10
Generic · 2
盐酸阿莫罗芬搽剂 · No verified English name 1 records · Latest accepted 2026/09/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602275 | Generic | 2026/09/15 | Shanxi Tongda Pharmaceutical CO., Ltd.; Zhejiang CDMO Pharmaceutical Co., Ltd. | CDE ↗ |
Febuxostat Tablets 2 records · Latest accepted 2026/08/20
Generic · 2
Azithromycin Tablets 4 records · Latest accepted 2026/06/04
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601061 | Supplement | 2026/06/04 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| CYHB2601060 | Supplement | 2026/06/04 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| CYHS2300043 | Generic | 2023/01/06 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| CYHS2300042 | Generic | 2023/01/06 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Iguratimod Tablets 1 records · Latest accepted 2026/04/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600901 | Generic | 2026/04/21 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Epinastine Hydrochloride Tablets 2 records · Latest accepted 2026/03/31
Generic · 2
Loxoprofen Sodium Tablets 1 records · Latest accepted 2026/02/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600508 | Generic | 2026/02/25 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Eperisone Hydrochloride Tablets 1 records · Latest accepted 2025/12/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504270 | Generic | 2025/12/12 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Amoxicillin Capsules 1 records · Latest accepted 2025/12/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502496 | Supplement | 2025/12/09 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Mecobalamin Tablets 1 records · Latest accepted 2025/12/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504176 | Generic | 2025/12/05 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Perindopril Arginine and Amlodipine Besylate Tablets(III) 1 records · Latest accepted 2025/11/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2502352 | Supplement | 2025/11/14 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Phenoxymethylpenicillin Potassium Tablets 1 records · Latest accepted 2025/11/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2550362 | Supplement | 2025/11/11 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Benidipine Hydrochloride Tablets 1 records · Latest accepted 2025/09/05
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503279 | Generic | 2025/09/05 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Bisoprolol Fumarate and Amlodipine Besylate Tablets 1 records · Latest accepted 2025/08/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503085 | Generic | 2025/08/22 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Perindopril arginine and amlodipine besylate tablets 2 records · Latest accepted 2025/07/15
Supplement · 1Generic · 1
Roxadustat Capsules 2 records · Latest accepted 2025/06/11
Generic · 2
Olmesartan Medoxomil and Amlodipine Besylate Tablets 1 records · Latest accepted 2025/05/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501872 | Generic | 2025/05/24 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
盐酸头孢他美酯分散片 · No verified English name 1 records · Latest accepted 2025/05/17
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501003 | Supplement | 2025/05/17 | Shanxi Tongda Pharmaceutical CO., Ltd.; Zhejiang Sha Pu Ai Si Pharma Co., Ltd. romanized | CDE ↗ |
Oseltamivir Phosphate For Oral Suspension 1 records · Latest accepted 2025/05/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500990 | Supplement | 2025/05/16 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Ferrous Succinate Tablets 1 records · Latest accepted 2025/03/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501200 | Generic | 2025/03/27 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Ibuprofen Suspension 1 records · Latest accepted 2025/01/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500536 | Generic | 2025/01/27 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Procaterol Hydrochloride Oral Solution 2 records · Latest accepted 2025/01/23
Supplement · 2
复方氨酚烷胺片 · No verified English name 1 records · Latest accepted 2024/11/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2402023 | Supplement | 2024/11/30 | Shanxi Tongda Pharmaceutical CO., Ltd.; Jiangxi Hai Er Si Pharma Co., Ltd. romanized | CDE ↗ |
Amoxicillin and Clavulanate Potassium Tablets 3 records · Latest accepted 2024/11/23
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401977 | Supplement | 2024/11/23 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| CYHB2401976 | Supplement | 2024/11/23 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| CYHB2100079 | Supplement | 2021/01/13 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
沙格列汀二甲双胍缓释片(II) · No verified English name 1 records · Latest accepted 2024/11/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404004 | Generic | 2024/11/21 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2024/11/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404005 | Generic | 2024/11/21 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
诺氟沙星胶囊 · No verified English name 1 records · Latest accepted 2024/10/13
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401653 | Supplement | 2024/10/13 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Glucosamine Sulfate Capsules 1 records · Latest accepted 2024/10/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401617 | Supplement | 2024/10/11 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Ibuprofen Sustained Release Capsules 1 records · Latest accepted 2024/09/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403158 | Generic | 2024/09/25 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Ursodeoxycholic Acid Capsules 1 records · Latest accepted 2024/07/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402274 | Generic | 2024/07/19 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Saxagliptin and Metformin Hydrochloride Sustained-release Tablets 1 records · Latest accepted 2024/04/18
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401161 | Generic | 2024/04/18 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Ebastine Oral Solution 1 records · Latest accepted 2024/01/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400286 | Generic | 2024/01/20 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Metformin Hydrochloride Extended-release Tablets 2 records · Latest accepted 2023/12/08
Supplement · 2
Ambroxol Hydrochloride and Clenbuterol Hydrochloride Oral Solution 1 records · Latest accepted 2023/03/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300730 | Generic | 2023/03/08 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Memantine Hydrochloride Tablets 1 records · Latest accepted 2023/02/16
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2300299 | Supplement | 2023/02/16 | Shanxi Tongda Pharmaceutical CO., Ltd.; Ningbo Shuang Cheng Pharma Co., Ltd. romanized | CDE ↗ |
Nitrendipine Tablets 1 records · Latest accepted 2022/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201396 | Supplement | 2022/08/10 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
盐酸林可霉素胶囊 · No verified English name 1 records · Latest accepted 2022/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201395 | Supplement | 2022/08/10 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
盐酸雷尼替丁胶囊 · No verified English name 1 records · Latest accepted 2022/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201397 | Supplement | 2022/08/10 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
硝苯地平片 · No verified English name 1 records · Latest accepted 2022/08/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201398 | Supplement | 2022/08/10 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
人工牛黄甲硝唑胶囊 · No verified English name 1 records · Latest accepted 2022/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201392 | Supplement | 2022/08/09 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
咳特灵胶囊 · No verified English name 1 records · Latest accepted 2022/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYZB2200900 | Supplement | 2022/08/09 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
Erythromycin Ethylsuccinate Granules 1 records · Latest accepted 2022/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201391 | Supplement | 2022/08/09 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
葡萄糖酸钙片 · No verified English name 1 records · Latest accepted 2022/08/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201393 | Supplement | 2022/08/09 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Qian Yuan Pharmaceuticals Group Co., Ltd. romanized | CDE ↗ |
Atosiban Acetate Injection 2 records · Latest accepted 2022/05/28
Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200798 | Generic | 2022/05/28 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2200797 | Generic | 2022/05/28 | Shanxi Tongda Pharmaceutical CO., Ltd.; Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Etoricoxib Tablets 2 records · Latest accepted 2022/04/06
Generic · 2
头孢地尼颗粒 · No verified English name 1 records · Latest accepted 2022/03/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200437 | Generic | 2022/03/11 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Metronidazole Tablets 1 records · Latest accepted 2022/01/18
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250049 | Supplement | 2022/01/18 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Nifedipine Controlled-release Tablets 1 records · Latest accepted 2021/12/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2102217 | Generic | 2021/12/17 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Amoxicillin Dispersible Tablets 1 records · Latest accepted 2021/02/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100263 | Supplement | 2021/02/23 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
阿莫西林克拉维酸钾片(4:1) · No verified English name 1 records · Latest accepted 2021/01/29
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150082 | Supplement | 2021/01/29 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Changes in the last 90 days
7 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Marketing application approved: 1 applicationAccepted: 3 applicationsNo longer listed under review: 3 applications
- 2026/11/14No longer listed under review
Roxadustat Capsules
CYHS2502066
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/06/11
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/14No longer listed under review
Roxadustat Capsules
CYHS2502065
Fact date: 2026/11/14 · Date added to this site: 2026/11/14
Accepted: 2025/06/11
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/10Marketing application approved
Ibuprofen Suspension
CYHS2500536 · 国药准字H20266524
Fact date: 2026/11/10 · Publication date: 2026/11/13 · Date added to this site: 2026/11/14
View source · Table row 46 ↗ - 2026/10/23No longer listed under review
Ibuprofen Suspension
CYHS2500536
Fact date: 2026/10/23 · Date added to this site: 2026/10/23
Accepted: 2025/01/27
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/13 (approval no.: 国药准字H20266524; approval date: 2026/11/10) · NMPA source · row 46
NMPA · Table row 46 ↗ View source ↗ - 2026/10/10Accepted
Allopurinol Tablets
CYHS2602482
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/10/10Accepted
Allopurinol Tablets
CYHS2602481
Fact date: 2026/10/10 · Date added to this site: 2026/10/22
View source ↗ - 2026/09/15Accepted
盐酸阿莫罗芬搽剂 · No verified English name
CYHS2602275
Fact date: 2026/09/15 · Date added to this site: 2026/10/22
View source ↗
Under review
17 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Allopurinol Tablets | CYHS2602482 | Generic | 2026/10/10 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Allopurinol Tablets | CYHS2602481 | Generic | 2026/10/10 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 盐酸阿莫罗芬搽剂 · No verified English name | CYHS2602275 | Generic | 2026/09/15 | Shanxi Tongda Pharmaceutical CO., Ltd.; Zhejiang CDMO Pharmaceutical Co., Ltd. | CDE ↗ |
| Febuxostat Tablets | CYHS2602060 | Generic | 2026/08/20 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Febuxostat Tablets | CYHS2602059 | Generic | 2026/08/20 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Iguratimod Tablets | CYHS2600901 | Generic | 2026/04/21 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Epinastine Hydrochloride Tablets | CYHS2600751 | Generic | 2026/03/31 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Epinastine Hydrochloride Tablets | CYHS2600750 | Generic | 2026/03/31 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Loxoprofen Sodium Tablets | CYHS2600508 | Generic | 2026/02/25 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Eperisone Hydrochloride Tablets | CYHS2504270 | Generic | 2025/12/12 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Amoxicillin Capsules | CYHB2502496 | Supplement | 2025/12/09 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Mecobalamin Tablets | CYHS2504176 | Generic | 2025/12/05 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Perindopril Arginine and Amlodipine Besylate Tablets(III) | CYHB2502352 | Supplement | 2025/11/14 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Phenoxymethylpenicillin Potassium Tablets | CYHB2550362 | Supplement | 2025/11/11 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Benidipine Hydrochloride Tablets | CYHS2503279 | Generic | 2025/09/05 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Bisoprolol Fumarate and Amlodipine Besylate Tablets | CYHS2503085 | Generic | 2025/08/22 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Ferrous Succinate Tablets | CYHS2501200 | Generic | 2025/03/27 | Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
Catalogue holder records
28 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Perindopril arginine and amlodipine besylate tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20269212 | 2026/08/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil and Amlodipine Besylate Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20265675 | 2026/08/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20264601 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| 沙格列汀二甲双胍缓释片(II) · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20264600 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ibuprofen Sustained Release Capsules | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20256328 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin and Metformin Hydrochloride Sustained-release Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20255782 | 2025/10/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ursodeoxycholic Acid Capsules | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20255784 | 2025/10/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Perindopril arginine and amlodipine besylate tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20254421 | 2025/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metformin Hydrochloride Extended-release Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20100173 | 2024/10/12 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 头孢地尼颗粒 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20244912 | 2024/09/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20243863 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20243862 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20243133 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20243132 | 2024/02/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atosiban Acetate Injection | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20234665 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Atosiban Acetate Injection | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Wei Qi Da Guang Ming Pharmaceutical Co., Ltd. romanized | 国药准字H20234666 | 2023/12/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nifedipine Controlled-release Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20234580 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Metronidazole Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H14022863 | 2023/08/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20063684 | 2022/10/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20227132 | 2022/10/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 诺氟沙星胶囊 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H14023224 | 2022/07/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20227028 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20000492 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20000491 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amoxicillin Dispersible Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20000493 | 2022/03/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ambroxol Hydrochloride Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20213959 | 2021/12/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amlodipine Besylate Tablets | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H20213531 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amoxicillin Capsules | Shanxi Tongda Pharmaceutical CO., Ltd. | Shanxi Tongda Pharmaceutical CO., Ltd. | 国药准字H14023222 | 2020/05/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
22 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 醋酸阿托西班 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20260000538 | I | 2026/07/02 | CDE ↗ |
| 司美格鲁肽 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20250000541 | I | 2025/07/11 | CDE ↗ |
| 醋酸亮丙瑞林 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20240001375 | A | 2026/06/11 | CDE ↗ |
| 醋酸西曲瑞克 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20240000543 | A | 2026/01/28 | CDE ↗ |
| 盐酸利多卡因 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20240000068 | I | 2025/04/16 | CDE ↗ |
| 精氨酸培哚普利 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20230001291 | A | 2025/04/09 | CDE ↗ |
| 葡萄糖酸钙 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20220000759 | A | 2025/05/30 | CDE ↗ |
| 蛋白琥珀酸铁 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20220000529 | A | 2025/09/13 | CDE ↗ |
| 盐酸左沙丁胺醇 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20210001295 | A | 2026/06/02 | CDE ↗ |
| 硫酸钠 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20210000818 | A | 2023/06/28 | CDE ↗ |
| 胶体果胶铋 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190007047 | A | 2023/03/24 | CDE ↗ |
| 比沙可啶 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190006370 | A | 2025/12/31 | CDE ↗ |
| 柳氮磺吡啶 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190004606 | A | 2025/03/22 | CDE ↗ |
| 盐酸利多卡因 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190004605 | A | 2025/06/13 | CDE ↗ |
| 磷酸苯丙哌林 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190004588 | A | 2026/08/28 | CDE ↗ |
| 葡萄糖酸锌 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190004574 | A | 2025/06/13 | CDE ↗ |
| 二氧化钛 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190001972 | A | 2026/07/10 | CDE ↗ |
| 硫酸氨基葡萄糖 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20190001359 | A | 2026/02/27 | CDE ↗ |
| 奥拉西坦 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20170001281 | I | — | CDE ↗ |
| 帕立骨化醇 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20170001227 | A | 2025/09/23 | CDE ↗ |
| 盐酸莫西沙星 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20170001220 | A | 2022/10/24 | CDE ↗ |
| 米力农 · No verified English name | Shanxi Tongda Pharmaceutical CO., Ltd. | Y20170001000 | I | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
39 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 碳酸钙D3片(I) · No verified English name | CYHB2601891 | Supplement | 2026/10/14 | Hainan Jin Tai Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd.; Hebei Bai Tai Pharmaceutical Co., Ltd. romanized; Hebei Bai Shan Pharma Co., Ltd. romanized | CDE ↗ |
| Nystatin Oral Suspension | CYHS2601742 | Generic | 2026/07/21 | Beijing Yuan Fang Tong Da Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Iron Proteinsuccinylate Oral Solution | CYHB2600176 | Supplement | 2026/01/29 | Yi Nan Li Nuo Pharmaceutical Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 盐酸甲氧氯普胺口服溶液 · No verified English name | CYHS2600005 | Generic | 2026/01/05 | Beijing Yuan Fang Tong Da Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Cefcapene Pivoxil Hydrochloride Granules | CYHS2504185 | Generic | 2025/12/05 | Mu Yuan (Anhui) Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Cefcapene Pivoxil Hydrochloride Granules | CYHS2503617 | Generic | 2025/10/10 | Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 盐酸左西替利嗪口服滴剂 · No verified English name | CYHB2500294 | Supplement | 2025/02/14 | Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Perindopril arginine and amlodipine besylate tablets | CYHS2500289 | Generic | 2025/01/15 | Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Bilastine Oral Solution | CYHS2500069 | Generic | 2025/01/06 | Xizang Ao Si Bi Xiu Pharmaceuticals Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Loxoprofen Sodium Oral Solution | CYHS2404511 | Generic | 2024/12/25 | Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Perindopril arginine and amlodipine besylate tablets | CYHS2404330 | Generic | 2024/12/12 | Hangzhou He Ze Kun Yuan Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Memantine Hydrochloride OD Tablets | CYHS2404125 | Generic | 2024/11/30 | Chongqing Ben Li Fang Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Bilastine Oral Solution | CYHS2403147 | Generic | 2024/09/25 | Hainan Hai Ling Chemical Pharmaceutical Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Glucosamine Sulfate Capsules | CYHB2400670 | Supplement | 2024/05/18 | Hainan Jin Tai Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 盐酸左西替利嗪口服滴剂 · No verified English name | CYHS2400328 | Generic | 2024/01/24 | Guangdong Yue He Ze Drug Research Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Voriconazole for Oral Suspension | CYHS2400004 | Generic | 2024/01/03 | Guangdong Yue He Ze Drug Research Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Levocarnitine Oral Solution | CYHS2303420 | Generic | 2023/12/09 | Liaoning Nuo Wei Nuo Pharmaceutical Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Levocarnitine Oral Solution | CYHS2303419 | Generic | 2023/12/09 | Liaoning Nuo Wei Nuo Pharmaceutical Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2303054 | Generic | 2023/11/08 | Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2302681 | Generic | 2023/10/10 | Jinan Tong Lu Pharmaceuticals Technology Development Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Procaterol Hydrochloride Oral Solution | CYHS2301636 | Generic | 2023/06/16 | Guangdong Wen Jian Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Procaterol Hydrochloride Oral Solution | CYHS2301635 | Generic | 2023/06/16 | Guangdong Wen Jian Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Procaterol Hydrochloride Oral Solution | CYHS2301170 | Generic | 2023/04/26 | Nanjing Ai De Jia Biopharmaceutical Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Procaterol Hydrochloride Oral Solution | CYHS2301169 | Generic | 2023/04/26 | Nanjing Ai De Jia Biopharmaceutical Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Amoxicillin Dispersible Tablets | CYHB2300621 | Supplement | 2023/03/28 | Bai Shan Technology (Hu Zhou) Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 盐酸左西替利嗪口服滴剂 · No verified English name | CYHS2300828 | Generic | 2023/03/18 | Shanxi Hui Da Lin Xi Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | CYHS2300298 | Generic | 2023/02/02 | Jilin Sheng Shen Yuan Pharmaceuticals Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | CYHS2300297 | Generic | 2023/02/02 | Jilin Sheng Shen Yuan Pharmaceuticals Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Iron Proteinsuccinylate Oral Solution | CYHS2201491 | Generic | 2022/09/09 | Beijing Min Kang Bai Cao Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2201479 | Generic | 2022/09/08 | Zhejiang Gao Zhi Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Amoxicillin Dispersible Tablets | CYHB2201202 | Supplement | 2022/07/20 | Bai Shan Technology (Hu Zhou) Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2200785 | Generic | 2022/05/31 | Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Tadalafil Tablets | CYHS2200784 | Generic | 2022/05/31 | Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Oseltamivir Phosphate For Oral Suspension | CYHS2200589 | Generic | 2022/04/14 | Hong Yue Technology (Hu Zhou) Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| 碳酸钙D3片 · No verified English name | CYHB2200436 | Supplement | 2022/03/11 | Hainan Jin Tai Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd.; Hainan Sai Li Ke Pharma Co., Ltd. romanized | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | CYHS2102013 | Generic | 2021/11/17 | Shanghai Jin Cheng Su Zhi Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Oseltamivir Phosphate Capsules | CYHS2102014 | Generic | 2021/11/12 | Zhejiang Ling Chuang You Pin Pharma Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Glucosamine Sulfate Capsules | CYHS2101995 | Generic | 2021/11/09 | Shanxi Ze Tong Pharmaceuticals Technology Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
| Paracetamol Tablets | CYHS2101461 | Generic | 2021/07/21 | Beijing Yi Ling Pharmaceuticals Technology Development Co., Ltd. romanized; Shanxi Tongda Pharmaceutical CO., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.